Recurrent childhood lymphocytic leukemia. Clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission
- 1 December 1978
- Vol. 42 (6) , 2521-2528
- https://doi.org/10.1002/1097-0142(197812)42:6<2521::aid-cncr2820420603>3.0.co;2-4
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Perturbation of Cell Cycle of Human Leukaemic Myeloblasts in vivo by Cytosine ArabinosideScandinavian Journal of Haematology, 2009
- Sequential use of methotrexate, folinic acid, and cytosine arabinoside in the treatment of acute leukemiaPublished by Elsevier ,1976
- Chemotherapy of acute lymphoblastic leukemia in childrenAmerican Journal of Hematology, 1976
- Initial features and prognosis in 363 children with acute lymphocytic leukemiaCancer, 1975
- Cessation of Therapy during Complete Remission of Childhood Acute Lymphocytic LeukemiaNew England Journal of Medicine, 1974
- Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210Published by Elsevier ,1974
- La cinétique des myéloblastes leucémiques humains après cytosine-arabinosideActa Haematologica, 1973
- Synchronization and recruitment in acute leukemiaJournal of Clinical Investigation, 1971
- Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlatesJournal of Clinical Investigation, 1969
- Effects of cytosine arabinoside on the cell viability and uptake of deoxypyrimidine nucleosides in 15178Y cellsBiochemical Pharmacology, 1968